Afficher la couverture 'Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond | Facchinetti, F.' en grand format
/5

0 avis

Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond

Archive ouverte

Facchinetti, F. | Appetecchia, M. | Aragona, C. | Bevilacqua, A. | Bezerra Espinola, M. S. | Bizzarri, M. | d'Anna, R. | Dewailly, D. | Diamanti-Kandarakis, E. | Hernández Marín, I. | Kamenov, Z. A. | Kandaraki, E. | Laganà, A. S. | Monastra, G. | Montanino Oliva, M. | Nestler, J. E. | Orio, F. | Ozay, A. C. | Papalou, O. | Pkhaladze, L. | Porcaro, G. | Prapas, N. | Soulage, C. O. | Stringaro, A. | Wdowiak, A. | Unfer, V.

Edité par CCSD -

International audience. Introduction: This Experts' opinion provides an updated scientific support to gynecologists, obstetricians, endocrinologists, nutritionists, neurologists and general practitioners on the use of Inositols in the therapy of Polycystic Ovary Syndrome (PCOS) and non-insulin dependent (type 2) diabetes mellitus (NIDDM).Areas covered: This paper summarizes the physiology of Myo-Inositol (MI) and D-Chiro-Inositol (DCI), two important molecules present in human organisms, and their therapeutic role, also for treating infertility. Some deep differences between the physiological functions of MI and DCI, as well as their safety and intestinal absorption are discussed. Updates include new evidence on the efficacy exerted in PCOS by the 40:1 MI/DCI ratio, and the innovative approach based on alpha-lactalbumin to overcome the decreased therapeutic efficacy of Inositols in some patients.Expert opinion: The evidence suggests that MI, alone or with DCI in the 40:1 ratio, offers a promising treatment for PCOS and NIDDM. However, additional studies need to evaluate some still unresolved issues, such as the best MI/DCI ratio for treating NIDDM, the potential cost-effectiveness of reduced gonadotropins administration in IVF due to MI treatment, or the benefit of MI supplementation in ovulation induction with clomiphene citrate in PCOS patients.

Consulter en ligne

Suggestions

Du même auteur

Inositols: From Established Knowledge to Novel Approaches

Archive ouverte | Dinicola, S. | CCSD

International audience. Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction...

D-chiro-inositol in clinical practice: A perspective from The Experts Group on Inositol in Basic and Clinical Research (EGOI)

Archive ouverte | Dinicola, S. | CCSD

BACKGROUND: D-chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders. OBJECTIVES: This perspective seeks to ex...

Inositols in Polycystic Ovary Syndrome: An Overview on the Advances

Archive ouverte | Facchinetti, F. | CCSD

International audience. This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and d-chiro-inositol (DCI). In the human ovary, MI is a second messenger of follicle-stimulating hormon...

Chargement des enrichissements...